Literature DB >> 20045118

A serotonin transporter gene polymorphism predicts peripartum depressive symptoms in an at-risk psychiatric cohort.

Elisabeth B Binder1, D Jeffrey Newport, Elizabeth B Zach, Alicia K Smith, Todd C Deveau, Lori L Altshuler, Lee S Cohen, Zachary N Stowe, Joseph F Cubells.   

Abstract

BACKGROUND: Peripartum major depressive disorder (MDD) is a prevalent psychiatric disorder with potential detrimental consequences for both mother and child. Despite its enormous health care relevance, data regarding genetic predictors of peripartum depression are sparse. The aim of this study was to investigate associations of the serotonin-transporter linked polymorphic region (5-HTTLPR) genotype with peripartum MDD in an at-risk population.
METHODS: Two hundred and seventy four women with a prior history of MDD were genotyped for 5-HTTLPR and serially evaluated in late pregnancy (gestational weeks 31-40), early post-partum (week 1-8) and late post-partum (week 9-24) for diagnosis of a current major depressive episode (MDE) and depressive symptom severity.
RESULTS: 5-HTTLPR S-allele carrier status predicted the occurrence of a MDE in the early post-partum period only (OR=5.13, p=0.017). This association persisted despite continued antidepressant treatment.
CONCLUSIONS: The 5-HTTLPR genotype may be a clinically relevant predictor of early post-partum depression in an at-risk population.
OBJECTIVE: Peripartum major depressive disorder is a prevalent psychiatric disorder with potential detrimental consequences for both mother and child. Despite its enormous health care relevance, data regarding genetic predictors of peripartum depression are sparse. The aim of this study was to investigate associations of the serotonin-transporter linked polymorphic region (5-HTTLPR) genotype with peripartum MDD in an at-risk population. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20045118      PMCID: PMC2891911          DOI: 10.1016/j.jpsychires.2009.12.001

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  42 in total

1.  Effects of gonadal steroids in women with a history of postpartum depression.

Authors:  M Bloch; P J Schmidt; M Danaceau; J Murphy; L Nieman; D R Rubinow
Journal:  Am J Psychiatry       Date:  2000-06       Impact factor: 18.112

2.  Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion.

Authors:  F A Moreno; D C Rowe; B Kaiser; D Chase; T Michaels; J Gelernter; P L Delgado
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

3.  Cohort study of depressed mood during pregnancy and after childbirth.

Authors:  J Evans; J Heron; H Francomb; S Oke; J Golding
Journal:  BMJ       Date:  2001-08-04

Review 4.  Maternal depression: a child's first adverse life event.

Authors:  D Jeffrey Newport; Molly M Wilcox; Zachary N Stowe
Journal:  Semin Clin Neuropsychiatry       Date:  2002-04

5.  Clinically identified maternal depression before, during, and after pregnancies ending in live births.

Authors:  Patricia M Dietz; Selvi B Williams; William M Callaghan; Donald J Bachman; Evelyn P Whitlock; Mark C Hornbrook
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

6.  Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression.

Authors:  Alexander Neumeister; Anastasios Konstantinidis; Juergen Stastny; Markus J Schwarz; Oliver Vitouch; Matthaus Willeit; Nicole Praschak-Rieder; Johanna Zach; Martina de Zwaan; Brigitta Bondy; Manfred Ackenheil; Siegfried Kasper
Journal:  Arch Gen Psychiatry       Date:  2002-07

7.  Maternal depression and infant cortisol: influences of timing, comorbidity and treatment.

Authors:  Patricia A Brennan; Rebecca Pargas; Elaine F Walker; Paula Green; D Jeffrey Newport; Zachary Stowe
Journal:  J Child Psychol Psychiatry       Date:  2008-05-19       Impact factor: 8.982

8.  Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

Authors:  Xian-Zhang Hu; A John Rush; Dennis Charney; Alexander F Wilson; Alexa J M Sorant; George J Papanicolaou; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Gonzalo Laje; Silvia Paddock; Francis J McMahon; Husseini Manji; Robert H Lipsky
Journal:  Arch Gen Psychiatry       Date:  2007-07

Review 9.  Parental depression: animal models of an adverse life event.

Authors:  D Jeffrey Newport; Zachary N Stowe; Charles B Nemeroff
Journal:  Am J Psychiatry       Date:  2002-08       Impact factor: 18.112

10.  Molecular genetic studies of bipolar disorder and puerperal psychosis at two polymorphisms in the estrogen receptor alpha gene (ESR 1).

Authors:  I Jones; F Middle; F McCandless; N Coyle; E Robertson; I Brockington; C Lendon; N Craddock
Journal:  Am J Med Genet       Date:  2000-12-04
View more
  23 in total

Review 1.  Reproductive Affective Disorders: a Review of the Genetic Evidence for Premenstrual Dysphoric Disorder and Postpartum Depression.

Authors:  Katherine McEvoy; Lauren M Osborne; Julie Nanavati; Jennifer L Payne
Journal:  Curr Psychiatry Rep       Date:  2017-10-30       Impact factor: 5.285

2.  Bidirectional psychoneuroimmune interactions in the early postpartum period influence risk of postpartum depression.

Authors:  Elizabeth J Corwin; Kathleen Pajer; Sudeshna Paul; Nancy Lowe; Mary Weber; Donna O McCarthy
Journal:  Brain Behav Immun       Date:  2015-04-29       Impact factor: 7.217

Review 3.  The role of reproductive hormones in postpartum depression.

Authors:  Crystal Edler Schiller; Samantha Meltzer-Brody; David R Rubinow
Journal:  CNS Spectr       Date:  2014-09-29       Impact factor: 3.790

4.  DOES SCREENING WITH THE MDQ AND EPDS IMPROVE IDENTIFICATION OF BIPOLAR DISORDER IN AN OBSTETRICAL SAMPLE?

Authors:  Crystal T Clark; Dorothy K Y Sit; Kara Driscoll; Heather F Eng; Andrea L Confer; James F Luther; Stephen R Wisniewski; Katherine L Wisner
Journal:  Depress Anxiety       Date:  2015-06-08       Impact factor: 6.505

Review 5.  Postpartum depression: A systematic review of the genetics involved.

Authors:  Tiago Castro E Couto; Mayra Yara Martins Brancaglion; António Alvim-Soares; Lafaiete Moreira; Frederico Duarte Garcia; Rodrigo Nicolato; Regina Amélia Lopes P Aguiar; Henrique Vitor Leite; Humberto Corrêa
Journal:  World J Psychiatry       Date:  2015-03-22

6.  Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings.

Authors:  Katherine L Wisner; Dorothy K Y Sit; Mary C McShea; David M Rizzo; Rebecca A Zoretich; Carolyn L Hughes; Heather F Eng; James F Luther; Stephen R Wisniewski; Michelle L Costantino; Andrea L Confer; Eydie L Moses-Kolko; Christopher S Famy; Barbara H Hanusa
Journal:  JAMA Psychiatry       Date:  2013-05       Impact factor: 21.596

7.  One-Year Developmental Outcomes for Infants of Mothers With Bipolar Disorder.

Authors:  Aimee K Santucci; Lynn T Singer; Stephen R Wisniewski; James F Luther; Heather F Eng; Dorothy K Sit; Katherine L Wisner
Journal:  J Clin Psychiatry       Date:  2017 Sep/Oct       Impact factor: 4.384

Review 8.  Biological and psychosocial predictors of postpartum depression: systematic review and call for integration.

Authors:  Ilona S Yim; Lynlee R Tanner Stapleton; Christine M Guardino; Jennifer Hahn-Holbrook; Christine Dunkel Schetter
Journal:  Annu Rev Clin Psychol       Date:  2015       Impact factor: 18.561

9.  Life stressors and 5-HTTLPR interaction in relation to midpregnancy depressive symptoms among African-American women.

Authors:  Jeanette M Scheid; Claudia B Holzman; Nicole Jones; Karen H Friderici; Katherine A Jernigan; Laura L Symonds; Alla Sikorskii; Rachel Fisher
Journal:  Psychiatr Genet       Date:  2011-12       Impact factor: 2.458

Review 10.  Pharmacotherapy of postpartum depression: an update.

Authors:  Deborah R Kim; C Neill Epperson; Amy R Weiss; Katherine L Wisner
Journal:  Expert Opin Pharmacother       Date:  2014-04-29       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.